FEDERALhearing transcript

Congressional Hearing: Global Update on Alzheimer's Disease

Original title: A GLOBAL UPDATE ON ALZHEIMER'S DISEASE

January 1, 2018

Alzheimer's disease Global health Dementia research Public health policy Caregiver support

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

The hearing serves as a formal record of congressional oversight into global Alzheimer's trends, which informs future federal funding priorities and international health policy strategies for research and caregiver support.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Alzheimer's patients and caregivers

The hearing addresses research and support programs that directly impact the care and management of the disease.

National Institutes of Health

Agency officials provided testimony regarding their ongoing research and global health initiatives.

What changed

Last recorded activity January 1, 2018.

What's next

Next step not available in the current record.

Summary

This document is a transcript of a 2017 House hearing regarding the global prevalence and impact of Alzheimer's disease. Experts from the National Institutes of Health and research institutions provided testimony on the disease's growth and potential support interventions.

Key Facts

Approximately 47 million people worldwide were living with Alzheimer's disease or other forms of dementia as of 2017.
The number of people living with Alzheimer's is projected to double every 20 years.
The hearing was held on November 29, 2017, in the Rayburn House Office Building.
The subcommittee reviewed the 'New York University Caregiver Intervention' and its potential for healthcare cost savings.
The hearing included testimony from representatives of the National Institutes of Health, NYU, the Global Alzheimer's Platform Foundation, and Splaine Consulting.

Frequently Asked Questions

What was the purpose of this hearing?

The met to receive a global update on the prevalence of Alzheimer's disease and discuss research and support strategies.

How many people are affected by Alzheimer's globally?

As of the 2017 hearing, an estimated 47 million people were living with Alzheimer's or other forms of .

Why It Matters

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Focus on Caregiver Economics

The inclusion of the 'Minnesota Economic Model of Dementia' suggests a shift toward justifying caregiver support programs through healthcare cost-savings analysis.

Mary Mittelman

Connected Entities

personRoger Glass“Director, Fogarty International Center, NIH”Map →

personChristopher H. Smith“Chairman of the Subcommittee on Africa, Global Health, Global Human Rights, and ”Map →

personRichard Mohs“Chief scientific officer, Global Alzheimer's Platform Foundation”Map →

personMarie Bernard“Deputy Director, National Institute on Aging”Map →

personMary Mittelman“Research professor, NYU”Map →

personMichael Splaine“Principal, Splaine Consulting”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100

Significance60
How much this matters to a regular citizen
Controversy10
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz10
Current news / social attention level

Publisher tools